## CEG: Constellation Energy Corporatio - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 1.8% below STRENGTH zone (3.0-6.0%); PEG 3.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($323.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Constellation Energy (CEG) Stock News Today: NRC Extends Key Nuclear Licenses, Calpine Deal Nears Closing, and Analysts Refresh Price Targets (Dec. 17, 2025)**
- Source: ts2.tech | 20251217T200826 | Somewhat-Bullish | Relevance: 100%
- Constellation Energy (CEG) stock is under scrutiny due to recent nuclear license renewals by the NRC for Illinois plants and progress on the Calpine acquisition, which included DOJ-mandated divestitures. Despite strong fundamental news, the stock experienced a sharp drop, influenced by a broader "risk-off" trend in AI-linked investments. Analysts have largely maintained positive outlooks, with refreshed price targets ranging from $410 to $481, reflecting the company's long-term strategic relevance amid increasing AI power demand.

**2. NRC Renews Operating Licenses for Clinton & Dresden; Constellation Investing $370 Million in State-of-the-Art Upgrades to Keep These Illinois Nuclear Facilities Online, Meet Rising Power Demand and Support Economic Growth**
- Source: Constellation Energy | 20251216T190943 | Bullish | Relevance: 100%
- The NRC has renewed operating licenses for Constellation's Clinton and Dresden Clean Energy Centers for 20 years, preserving over 2,200 jobs and generating $8.1 billion in tax revenues. Constellation is investing more than $370 million in state-of-the-art upgrades to these facilities, ensuring their continued safety, reliability, and efficiency. This renewal supports Illinois's clean energy future and economic growth by guaranteeing a continued supply of carbon-free power for decades.

**3. Constellation Energy Corporation (CEG) Receives a Buy from Bank of America Securities**
- Source: The Globe and Mail | 20251216T115504 | Bullish | Relevance: 100%
- Bank of America Securities analyst Ross Fowler maintained a Buy rating for Constellation Energy Corporation (CEG) with a price target of $407.00. Fowler has a 5.4% average return and 58.12% success rate on recommended stocks. This comes as Constellation Energy reported strong Q3 earnings with $7.18 billion in revenue and $930 million in net profit.

**4. Evaluating Constellation Energy (CEG) Stock's Actual Performance**
- Source: Finviz | 20251216T050745 | Bullish | Relevance: 100%
- Constellation Energy (CEG) has demonstrated strong financial performance since its 2022 spinoff from Exelon, driven by a resurgence in demand for nuclear energy. The company boasts impressive total returns that have significantly outpaced the S&P 500, fueled by strategic power purchase agreements with major tech companies like Microsoft and Meta. Its acquisition of Calpine is set to further boost earnings, positioning CEG for continued growth.

**5. Constellation Energy (CEG) Stock After Hours Today (Dec. 17, 2025): Why Shares Fell and What to Watch Before Thursdayâ€™s Open**
- Source: ts2.tech | 20251218T000926 | Neutral | Relevance: 100%
- Constellation Energy (CEG) stock experienced a sharp selloff during regular trading on December 17, 2025, driven by a broader market wobble in AI-related stocks. However, shares bounced back in after-hours trading following late-breaking news about PJM capacity auction results. Investors are now watching AI capital expenditure headlines, PJM follow-through, and upcoming macro data like CPI before Thursday's market open.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $420 | $385 | +9% |
| 2025-12-16 | JP Morgan | $410 | $422 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Buy |
| 2025-12-16 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.13M) |
| Sells | 1 ($4.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.1%)
- Capital Internationa: 8.4% (-7.3%)
- Blackrock Inc.: 7.2% (+0.8%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.2% (-6.8%)

### Key Risks

1. Insider selling cluster: $4.5M in recent transactions.
2. Valuation stretched: PEG 3.6x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +3.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.63 signals overvaluation risk, limited margin of safety. Balance sheet: $1.5B free cash flow. Insider selling cluster ($4.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $112.8B |
| Beta | 1.14 |
| 52W Range | $161.35 - $412.70 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.63 |
| Forward P/E | 31.1 |
| Current P/E | 38.7 |
| YoY Growth | 24.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to 1.8% (+3.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.2pp (needs >3.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. RSI neutral at 51. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.75% (CS: 62) | Neutral |
| RSI_14 | 51.0 | Neutral |
| MACD Histogram | -0.43 | Bearish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 0.990x | Below |
| vs SMA200 | 1.178x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $361.05
- **Stop Loss:** $323.31 (10.5% risk)
- **Target:** $398.79 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 25
- **Position Value:** $9,026.25
- **Portfolio %:** 9.03%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-17 (Est: $2.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.12 | $3.04 | -2.6% |
| 2025Q2 | $1.83 | $1.91 | +4.2% |
| 2025Q1 | $2.21 | $2.14 | -3.1% |
| 2024Q4 | $2.14 | $2.44 | +14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*